OncoMatch

OncoMatch/Clinical Trials/NCT05179889

Adjuvant mFOLFIRINOX for High-risk Stage III Colon Cancer

Is NCT05179889 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2/3 trial studies multiple treatments including mFOLFIRINOX and mFOLFOX 6 for colon cancer stage iii.

Phase 2/3RecruitingChungnam National University HospitalNCT05179889Data as of Jun 2026Location: South Korea

Treatment: mFOLFIRINOX · mFOLFOX 6A multicenter, open labeled randomized, phase II trial comparing mFOLFIRINOX and mFOLFOX6 as adjuvant treatment for high risk stage III (pT4N1/2 or pTanyN2) colon cancer

Check if I qualify

Extracted eligibility criteria

Treatments studied

Other

mFOLFIRINOXmFOLFOX 6

Cancer type

Colorectal Cancer

Disease stage

Required: Stage III

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Demographics

Ages 20–75

Prior therapy

Must have received: surgery — curative radical resection (successful R0 resection) within 60 days before randomization

Curative radical resection (successful R0 resection) within 60 days before randomization

Lab requirements

Blood counts

ANC ≥ 2×10^6 cells/mL; hemoglobin ≥ 9.0 g/dL; platelets ≥ 100×10^6 cells/mL

Kidney function

serum creatinine ≤1.5 × ULN or creatinine clearance > 50 mL/min (Cockcroft-Gault formula)

Liver function

ALT/AST ≤2.5 × ULN; serum total bilirubin ≤ 1.5 ULN; alkaline phosphatase ≤ 2.5 × ULN

Adequate organ functions: ANC ≥ 2×10^6 cells/mL; Hemoglobin ≥ 9.0 g/dL; Platelets ≥ 100×10^6 cells/mL; ALT/AST ≤2.5 × ULN; serum total bilirubin ≤ 1.5 ULN; alkaline phosphatase ≤ 2.5 × ULN; serum creatinine ≤1.5 × ULN or creatinine clearance > 50 mL/min (Cockcroft-Gault formula)

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT05179889 currently recruiting?

Yes, this trial is currently recruiting patients.

Is prior treatment required for enrollment?

Yes. Patients must have previously received surgery.

What disease stage is eligible?

Stage III is required.

Is there an age limit?

Yes. Patients must be 75 years or younger and at least 20 years old.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify